Evidence map›Paper›PMID 40759751›Full record

ArticleNature metabolism2025

Classically activated macrophages undergo functionally significant nucleotide metabolism remodelling driven by nitric oxide.

Steven V John, Gretchen L Seim, Billy J Erazo-Flores, James A Votava, Uzziah S Urquiza, Nicholas L Arp, John Steill, Jack Freeman, Lauren N Carnevale, Isaiah Roberts and 5 more

Abstract read
In one paragraph

Article in Nature metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Metabolomics ofbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Research square · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Steven V JohnMorgridge Institute for Research, Madison, WI, USA.ORCID http://orcid.org/0000-0002-7967-1864
Gretchen L SeimMorgridge Institute for Research, Madison, WI, USA.
Billy J Erazo-FloresCellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA.
James A VotavaMorgridge Institute for Research, Madison, WI, USA.
Uzziah S UrquizaMorgridge Institute for Research, Madison, WI, USA.
Nicholas L ArpMorgridge Institute for Research, Madison, WI, USA.ORCID http://orcid.org/0000-0001-8709-0667
John SteillMorgridge Institute for Research, Madison, WI, USA.
Jack FreemanMorgridge Institute for Research, Madison, WI, USA.
Lauren N CarnevaleNeurodegeneration New Medicines Center and Department of Molecular & Cellular Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-0451-0481
Isaiah RobertsMorgridge Institute for Research, Madison, WI, USA.
Xin QingMorgridge Institute for Research, Madison, WI, USA.ORCID http://orcid.org/0000-0002-3579-706X
Stuart A LiptonNeurodegeneration New Medicines Center and Department of Molecular & Cellular Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-3490-1259
Ron StewartMorgridge Institute for Research, Madison, WI, USA.
Laura J KnollCellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA.ORCID http://orcid.org/0000-0002-9362-8088
Jing FanMorgridge Institute for Research, Madison, WI, USA. jfan@morgridge.org.ORCID http://orcid.org/0000-0002-5326-5358

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
Biotechnology Training ProgramT32GM135066 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI SCOTT M. COYLE, BRIAN G FOX · 2020 to 2026
$7.0M
Parasitology and Vector Biology Training ProgramT32AI007414 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Lyric Colleen Bartholomay · 1992 to 2026
$4.5M
Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasitesR01AI172874 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI David J Beebe, LAURA J KNOLL · 2023 to 2026
$3.1M
Aberrant protein S-nitrosylation mediates Gene-Environment Interactions in AD/ADRDU01AG088679 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI STUART A LIPTON, Tomohiro Nakamura · 2024 to 2026
$2.7M
Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's diseaseR01AG078756 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI STUART A LIPTON · 2022 to 2026
$2.3M
Metabolic rewiring coupled to the production of reactive oxygen and nitrogen species (RONS)R35GM147014 · NIGMS · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI Jing Fan · 2022 to 2026
$2.1M
University of Wisconsin-Madison Postbaccalaureate Research Education Program (PREP) for increasing student preparedness in STEMR25GM144251 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Joan S Jorgensen · 2022 to 2026
$1.4M
Dynamic reprogramming of macrophage acetyl-CoA metabolism in endotoxin toleranceF30AI183563 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Nicholas Lawrence Arp · 2024 to 2026
$136k
The molecular mechanism and the functional role of pyruvate dehydrogenase complex regulation in macrophagesF31AI152280 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SEIM, GRETCHEN · 2021 to 2022
$52k
NCI NIH HHS P30 CA014520NIAID NIH HHS F30 AI183563NIAID NIH HHS F31 AI152280NIAID NIH HHS R01 AI172874NIAID NIH HHS T32 AI007414NIA NIH HHS R01 AG078756NIA NIH HHS U01 AG088679NIGMS NIH HHS R25 GM144251NIGMS NIH HHS R35 GM147014NIGMS NIH HHS T32 GM135066
6 · The paper itself

Abstract

During an immune response, macrophages specifically reprogramme their metabolism to support functional changes. Here, we revealed that nucleotide metabolism is one of the most significantly reprogrammed pathways upon classical activation. Specifically, de novo synthesis of pyrimidines is maintained up to uridine monophosphate, but blocked at cytidine triphosphate and deoxythymidine monophosphate synthesis; de novo synthesis of purines is shut off at the last step (catalysed by AICAR transformylase/IMP cyclohydrolase, ATIC), and cells switch to increased purine salvage. Nucleotide degradation to nitrogenous bases is upregulated but complete oxidation of purine bases (catalysed by xanthine oxidoreductase, XOR) is inhibited, diverting flux into salvage. Mechanistically, nitric oxide was identified as a major regulator of nucleotide metabolism, simultaneously driving multiple key changes, including the transcriptional downregulation of Tyms and profound inhibition of ATIC and XOR. Inhibiting purine salvage using Hgprt knockout or inhibition alters the expression of many stimulation-induced genes, suppresses macrophage migration and phagocytosis, and increases the proliferation of the intracellular parasite Toxoplasma gondii. Together, these results thoroughly uncover the dynamic reprogramming of macrophage nucleotide metabolism upon classical activation and elucidate the regulatory mechanisms and functional significance of such reprogramming.

Indexed as

Macrophage ActivationMacrophagesNitric OxideNucleotidesAnimalsMicePhagocytosisToxoplasmaNitric OxideNucleotides

Identifiers

PMID40759751
PMCPMC12356500

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.